Advisor Consultant Network’s Pfizer PFE Stock Holding History

Advisor Consultant Network’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$10.1M	Buy	+313,196	New	+$10.5M	1.43%	20

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Advisor Consultant Network's PFE Position: Q3 2016 in Review

Advisor Consultant Network opened a new position in Pfizer (PFE) in Q3 2016: 313,196 shares worth $10.1M. The stake represents 1.43% of the portfolio and ranks #20 among its holdings.

1,964 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Advisor Consultant Network held 313,196 shares of Pfizer worth $10.1M as of Q3 2016.
Pfizer was a new Advisor Consultant Network position in Q3 2016.
Pfizer made up 1.43% of Advisor Consultant Network's portfolio in Q3 2016, its #20 holding.
1,964 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Advisor Consultant Network's 13F filing for Q3 2016, filed 14 Oct 2016.